
LINK . SPRINGER . COM {
}
Title:
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience | Diabetologia
Description:
Aims/hypothesis Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular outcomes. Methods A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical, laboratory characteristics and study outcomes were examined by FACI status. Results Of the sample, 48% of those randomised to receive fenofibrate had at least a 20% increase in serum creatinine within 4 months. In multivariable analysis, participants who were older, male, used an ACE inhibitor at baseline, used a thiazolidinedione (TZD) at 4 months post-randomisation, had baseline CVD, and had lower baseline serum creatinine and LDL-cholesterol levels were all more likely to meet the criteria for FACI. Participants in the FACI group were also more likely to have a decrease in their serum triacylglycerol level from baseline to 4 months. No differences in study outcomes were seen by FACI criteria. Conclusions/interpretation Several characteristics predict a rapid rise in serum creatinine upon starting fenofibrate. Participants who met the criteria for FACI also had a greater change in triacylglycerol levels. In the setting of careful renal function surveillance and reduction of fenofibrate dose as indicated, no increase in renal disease or cardiovascular outcome was seen in those individuals demonstrating FACI. Trial registration: ClincalTrials.gov: NCT00000620 Funding: The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035 and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; by General Clinical Research Centers and by the Clinical and Translational Science Awards. Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, sanofi-aventis US and Takeda Pharmaceuticals provided study medications, equipment or supplies.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Health & Fitness
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,182 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
The income method remains a mystery to us.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.
Keywords {🔍}
creatinine, fenofibrate, participants, study, faci, renal, diabetes, baseline, increase, article, serum, google, scholar, accord, month, function, pubmed, clinical, cardiovascular, lipid, cas, level, trial, control, risk, patients, change, disease, usa, randomised, cvd, greater, table, characteristics, nhc, treatment, type, group, medication, analysis, research, levels, national, kidney, statin, placebo, status, tzd, blood, institute,
Topics {✒️}
peroxisome-proliferator-activated receptors alpha gov/scripts/cder/drugsatfda/index peroxisome proliferator-activated receptor chronic kidney disease-epidemiology peroxisome proliferator-activated receptors diabetes-induced experimental nephropathy pre-existing kidney disease albumin/creatinine ratio ≥ 35 mg/mmol open-label simvastatin therapy urinary albumin/creatinine ratio achieve ldl-cholesterol targets long-term renal function urinary/plasma inulin ratio long-term adverse effects end-stage renal disease long-term adverse effect urine albumin/creatinine ratio long-term fenofibrate therapy long-term fenofibrate treatment high-quality control samples abbott/merck schering plough/pfizer open-label simvastatin low-quality control samples long-term renal study cohort examined long-term efficacy privacy choices/manage cookies intra-assay cvs based raise hdl-cholesterol levels forward variable selection taking lipid-lowering medication statin ldl-cholesterol level full-dose medication 73 m2 received 54 mg/day albumin/creatinine ratio glomerular filtration rate sperl-hillen declare proteinuric renal disease kidney diseases urinary/plasma creatinine treatment strategy designed renal blood flow international diabetes center incident renal disease greater triacylglycerol-lowering response grey-filled boxes include genes related largest clinical trials mild renal insufficiency ldl-cholesterol level
Questions {❓}
- Broeders N, Knoop C, Antoine M, Tielemans C, Abramowicz D (2000) Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
Schema {🗺️}
WebPage:
mainEntity:
headline:Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
description:Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular outcomes. A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical, laboratory characteristics and study outcomes were examined by FACI status. Of the sample, 48% of those randomised to receive fenofibrate had at least a 20% increase in serum creatinine within 4 months. In multivariable analysis, participants who were older, male, used an ACE inhibitor at baseline, used a thiazolidinedione (TZD) at 4 months post-randomisation, had baseline CVD, and had lower baseline serum creatinine and LDL-cholesterol levels were all more likely to meet the criteria for FACI. Participants in the FACI group were also more likely to have a decrease in their serum triacylglycerol level from baseline to 4 months. No differences in study outcomes were seen by FACI criteria. Several characteristics predict a rapid rise in serum creatinine upon starting fenofibrate. Participants who met the criteria for FACI also had a greater change in triacylglycerol levels. In the setting of careful renal function surveillance and reduction of fenofibrate dose as indicated, no increase in renal disease or cardiovascular outcome was seen in those individuals demonstrating FACI.
Trial registration: ClincalTrials.gov: NCT00000620
Funding: The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035 and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; by General Clinical Research Centers and by the Clinical and Translational Science Awards. Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, sanofi-aventis US and Takeda Pharmaceuticals provided study medications, equipment or supplies.
datePublished:2012-03-27T00:00:00Z
dateModified:2012-03-27T00:00:00Z
pageStart:1641
pageEnd:1650
sameAs:https://doi.org/10.1007/s00125-012-2524-2
keywords:
Cardiovascular
Creatinine
Fenofibrate
Outcomes
Renal
Internal Medicine
Metabolic Diseases
Human Physiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2524-2/MediaObjects/125_2012_2524_Fig1_HTML.gif
isPartOf:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:D. E. Bonds
affiliation:
name:National Institutes of Health
address:
name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:T. E. Craven
affiliation:
name:Wake Forest School of Medicine
address:
name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
type:Organization
type:Person
name:J. Buse
affiliation:
name:University of North Carolina School of Medicine
address:
name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
type:PostalAddress
type:Organization
type:Person
name:J. R. Crouse
affiliation:
name:Wake Forest School of Medicine
address:
name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
type:Organization
type:Person
name:R. Cuddihy
affiliation:
name:International Diabetes Center
address:
name:International Diabetes Center, Minneapolis, USA
type:PostalAddress
type:Organization
name:US Medical Affairs of sanofi-aventis
address:
name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
type:PostalAddress
type:Organization
type:Person
name:M. Elam
affiliation:
name:Veteran’s Affairs Medical Center
address:
name:Veteran’s Affairs Medical Center, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:H. N. Ginsberg
affiliation:
name:Columbia University College of Physicians and Surgeons
address:
name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
type:PostalAddress
type:Organization
type:Person
name:K. Kirchner
affiliation:
name:Montgomery Veterans Administration Medical Center
address:
name:Montgomery Veterans Administration Medical Center, Jackson, USA
type:PostalAddress
type:Organization
type:Person
name:S. Marcovina
affiliation:
name:University of Washington
address:
name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:J. C. Mychaleckyj
affiliation:
name:University of Virginia
address:
name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
type:PostalAddress
type:Organization
type:Person
name:P. J. O’Connor
affiliation:
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
type:Organization
type:Person
name:J.-A. Sperl-Hillen
affiliation:
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
description:Fenofibrate has been noted to cause an elevation in serum creatinine in some individuals. Participants in the Action to Control Cardiovascular Risk in Diabetes Lipid Study were studied to better characterise who is at risk of an increase in creatinine level and to determine whether those with creatinine elevation have a differential risk of adverse renal or cardiovascular outcomes. A fenofibrate-associated creatinine increase (FACI) was defined as an increase in serum creatinine of at least 20% from baseline to month 4 in participants assigned to fenofibrate. Baseline patient characteristics, and baseline and 4-month drug, clinical, laboratory characteristics and study outcomes were examined by FACI status. Of the sample, 48% of those randomised to receive fenofibrate had at least a 20% increase in serum creatinine within 4 months. In multivariable analysis, participants who were older, male, used an ACE inhibitor at baseline, used a thiazolidinedione (TZD) at 4 months post-randomisation, had baseline CVD, and had lower baseline serum creatinine and LDL-cholesterol levels were all more likely to meet the criteria for FACI. Participants in the FACI group were also more likely to have a decrease in their serum triacylglycerol level from baseline to 4 months. No differences in study outcomes were seen by FACI criteria. Several characteristics predict a rapid rise in serum creatinine upon starting fenofibrate. Participants who met the criteria for FACI also had a greater change in triacylglycerol levels. In the setting of careful renal function surveillance and reduction of fenofibrate dose as indicated, no increase in renal disease or cardiovascular outcome was seen in those individuals demonstrating FACI.
Trial registration: ClincalTrials.gov: NCT00000620
Funding: The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035 and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; by General Clinical Research Centers and by the Clinical and Translational Science Awards. Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, sanofi-aventis US and Takeda Pharmaceuticals provided study medications, equipment or supplies.
datePublished:2012-03-27T00:00:00Z
dateModified:2012-03-27T00:00:00Z
pageStart:1641
pageEnd:1650
sameAs:https://doi.org/10.1007/s00125-012-2524-2
keywords:
Cardiovascular
Creatinine
Fenofibrate
Outcomes
Renal
Internal Medicine
Metabolic Diseases
Human Physiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-012-2524-2/MediaObjects/125_2012_2524_Fig1_HTML.gif
isPartOf:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:D. E. Bonds
affiliation:
name:National Institutes of Health
address:
name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:T. E. Craven
affiliation:
name:Wake Forest School of Medicine
address:
name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
type:Organization
type:Person
name:J. Buse
affiliation:
name:University of North Carolina School of Medicine
address:
name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
type:PostalAddress
type:Organization
type:Person
name:J. R. Crouse
affiliation:
name:Wake Forest School of Medicine
address:
name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
type:Organization
type:Person
name:R. Cuddihy
affiliation:
name:International Diabetes Center
address:
name:International Diabetes Center, Minneapolis, USA
type:PostalAddress
type:Organization
name:US Medical Affairs of sanofi-aventis
address:
name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
type:PostalAddress
type:Organization
type:Person
name:M. Elam
affiliation:
name:Veteran’s Affairs Medical Center
address:
name:Veteran’s Affairs Medical Center, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:H. N. Ginsberg
affiliation:
name:Columbia University College of Physicians and Surgeons
address:
name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
type:PostalAddress
type:Organization
type:Person
name:K. Kirchner
affiliation:
name:Montgomery Veterans Administration Medical Center
address:
name:Montgomery Veterans Administration Medical Center, Jackson, USA
type:PostalAddress
type:Organization
type:Person
name:S. Marcovina
affiliation:
name:University of Washington
address:
name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:J. C. Mychaleckyj
affiliation:
name:University of Virginia
address:
name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
type:PostalAddress
type:Organization
type:Person
name:P. J. O’Connor
affiliation:
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
type:Organization
type:Person
name:J.-A. Sperl-Hillen
affiliation:
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Diabetologia
issn:
1432-0428
0012-186X
volumeNumber:55
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:National Institutes of Health
address:
name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
type:PostalAddress
name:Wake Forest School of Medicine
address:
name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
name:University of North Carolina School of Medicine
address:
name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
type:PostalAddress
name:Wake Forest School of Medicine
address:
name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
name:International Diabetes Center
address:
name:International Diabetes Center, Minneapolis, USA
type:PostalAddress
name:US Medical Affairs of sanofi-aventis
address:
name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
type:PostalAddress
name:Veteran’s Affairs Medical Center
address:
name:Veteran’s Affairs Medical Center, Memphis, USA
type:PostalAddress
name:Columbia University College of Physicians and Surgeons
address:
name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
type:PostalAddress
name:Montgomery Veterans Administration Medical Center
address:
name:Montgomery Veterans Administration Medical Center, Jackson, USA
type:PostalAddress
name:University of Washington
address:
name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
type:PostalAddress
name:University of Virginia
address:
name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
type:PostalAddress
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:D. E. Bonds
affiliation:
name:National Institutes of Health
address:
name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
type:PostalAddress
type:Organization
email:[email protected]
name:T. E. Craven
affiliation:
name:Wake Forest School of Medicine
address:
name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
type:Organization
name:J. Buse
affiliation:
name:University of North Carolina School of Medicine
address:
name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
type:PostalAddress
type:Organization
name:J. R. Crouse
affiliation:
name:Wake Forest School of Medicine
address:
name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
type:PostalAddress
type:Organization
name:R. Cuddihy
affiliation:
name:International Diabetes Center
address:
name:International Diabetes Center, Minneapolis, USA
type:PostalAddress
type:Organization
name:US Medical Affairs of sanofi-aventis
address:
name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
type:PostalAddress
type:Organization
name:M. Elam
affiliation:
name:Veteran’s Affairs Medical Center
address:
name:Veteran’s Affairs Medical Center, Memphis, USA
type:PostalAddress
type:Organization
name:H. N. Ginsberg
affiliation:
name:Columbia University College of Physicians and Surgeons
address:
name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
type:PostalAddress
type:Organization
name:K. Kirchner
affiliation:
name:Montgomery Veterans Administration Medical Center
address:
name:Montgomery Veterans Administration Medical Center, Jackson, USA
type:PostalAddress
type:Organization
name:S. Marcovina
affiliation:
name:University of Washington
address:
name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:J. C. Mychaleckyj
affiliation:
name:University of Virginia
address:
name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
type:PostalAddress
type:Organization
name:P. J. O’Connor
affiliation:
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
type:Organization
name:J.-A. Sperl-Hillen
affiliation:
name:HealthPartners Research Foundation
address:
name:HealthPartners Research Foundation, Minneapolis, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, USA
name:Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, USA
name:Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, USA
name:Department of Medicine, Wake Forest School of Medicine, Winston-Salem, USA
name:International Diabetes Center, Minneapolis, USA
name:US Medical Affairs of sanofi-aventis, Bridegwater, USA
name:Veteran’s Affairs Medical Center, Memphis, USA
name:Department of Medicine, Columbia University College of Physicians and Surgeons, New York, USA
name:Montgomery Veterans Administration Medical Center, Jackson, USA
name:Northwest Lipid Metabolism and Diabetes Research Laboratory, University of Washington, Seattle, USA
name:Department of Public Health Sciences, University of Virginia, Charlottesville, USA
name:HealthPartners Research Foundation, Minneapolis, USA
name:HealthPartners Research Foundation, Minneapolis, USA
External Links {🔗}(120)
- How much profit does https://www.springernature.com/gp/authors generate?
- Discover the revenue of https://link.springernature.com/home/
- Check the income stats for https://order.springer.com/public/cart
- Income figures for https://mc.manuscriptcentral.com/diabetologia
- What are the total earnings of https://beta.springernature.com/pre-submission?journalId=125?
- What's the financial intake of http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails?
- How much revenue does https://doi.org/10.1001%2Fjama.2011.353 produce monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21427374?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Use%20of%20fibrates%20in%20the%20United%20States%20and%20Canada&journal=JAMA&doi=10.1001%2Fjama.2011.353&volume=305&pages=1217-1224&publication_year=2011&author=Jackevicius%2CCA&author=Tu%2CJV&author=Ross%2CJS&author=Ko%2CDT&author=Carreon%2CD&author=Krumholz%2CHM?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10081035
- How much does http://scholar.google.com/scholar_lookup?&title=Fenofibrate%20increases%20blood%20creatinine%2C%20but%20does%20not%20change%20the%20glomerular%20filtration%20rate%20in%20patients%20with%20mild%20renal%20insufficiency&journal=Nephrologie&volume=20&pages=41-44&publication_year=1999&author=Hottelart%2CC&author=el%20Esper%2CN&author=Achard%2CJM&author=Pruna%2CA&author=Fournier%2CA gross monthly?
- What's the monthly money flow for https://doi.org/10.1093%2Fndt%2F15.12.1993?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11096145
- How much income does http://scholar.google.com/scholar_lookup?&title=Fibrate-induced%20increase%20in%20blood%20urea%20and%20creatinine%3A%20is%20gemfibrozil%20the%20only%20innocuous%20agent%3F&journal=Nephrol%20Dial%20Transplant&doi=10.1093%2Fndt%2F15.12.1993&volume=15&pages=1993-1999&publication_year=2000&author=Broeders%2CN&author=Knoop%2CC&author=Antoine%2CM&author=Tielemans%2CC&author=Abramowicz%2CD have?
- What's the total monthly financial gain of https://doi.org/10.1053%2Fj.ajkd.2004.11.004?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15754270 bring in each month?
- How much money does http://scholar.google.com/scholar_lookup?&title=Fenofibrate%20reduces%20progression%20to%20microalbuminuria%20over%203%C2%A0years%20in%20a%20placebo-controlled%20study%20in%20type%202%20diabetes%3A%20results%20from%20the%20Diabetes%20Atherosclerosis%20Intervention%20Study%20%28DAIS%29&journal=Am%20J%20Kidney%20Dis&doi=10.1053%2Fj.ajkd.2004.11.004&volume=45&pages=485-493&publication_year=2005&author=Ansquer%2CJC&author=Foucher%2CC&author=Rattier%2CS&author=Taskinen%2CMR&author=Steiner%2CG make?
- https://doi.org/10.1016%2FS0140-6736%2805%2967667-2's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16310551 bring in each month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Effects%20of%20long-term%20fenofibrate%20therapy%20on%20cardiovascular%20events%20in%209795%20people%20with%20type%202%20diabetes%20mellitus%20%28the%20FIELD%20study%29%3A%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2805%2967667-2&volume=366&pages=1849-1861&publication_year=2005&author=Keech%2CA&author=Simes%2CRJ&author=Barter%2CP
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Design%20and%20intermediate%20results%20of%20the%20Lower%20Extremity%20Arterial%20Disease%20Event%20Reduction%20%28LEADER%29%2A%20trial%20of%20bezafibrate%20in%20men%20with%20lower%20extremity%20arterial%20disease%20%5BISRCTN4119421%5D&journal=Curr%20Contr%20Trials%20Cardiovasc%20Med&doi=10.1186%2FCVM-2-4-195&volume=2&pages=195-204&publication_year=2001&author=Meade%2CTW?
- What's the financial gain of https://doi.org/10.1177%2F107424840200700404?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Effect%20of%20ciprofibrate%20on%20lipoproteins%2C%20fibrinogen%2C%20renal%20function%2C%20and%20hepatic%20enzymes&journal=J%20Cardiovasc%20Pharmacol%20Therapeut&doi=10.1177%2F107424840200700404&volume=7&pages=219-226&publication_year=2002&author=Rizos%2CE&author=Bairaktari%2CE&author=Ganotakis%2CE&author=Tsimihodimos%2CV&author=Mikhailidis%2CDP&author=Elisaf%2CM produce monthly?
- What's the income generated by https://doi.org/10.1093%2Fndt%2F16.7.1515 each month?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11427661 generate?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Fibrate-induced%20increase%20in%20blood%20urea%20and%20creatinine&journal=Nephrol%20Dial%20Transplant&doi=10.1093%2Fndt%2F16.7.1515&volume=16&publication_year=2001&author=Lipscombe%2CJ&author=Bargman%2CJM each month?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11158224 earns monthly
- Find out how much http://scholar.google.com/scholar_lookup?&title=Comparative%20effects%20of%20cerivastatin%20and%20fenofibrate%20on%20the%20atherogenic%20lipoprotein%20phenotype%20in%20proteinuric%20renal%20disease&journal=J%20Am%20Soc%20Nephrol&volume=12&pages=341-348&publication_year=2001&author=Deighan%2CCJ&author=Caslake%2CMJ&author=McConnell%2CM&author=Boulton-Jones%2CJM&author=Packard%2CCJ earns monthly
- What's the profit of https://doi.org/10.1053%2Fj.ajkd.2008.01.014?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18501783?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Effect%20of%20fenofibrate%20on%20kidney%20function%3A%20a%206-week%20randomized%20crossover%20trial%20in%20healthy%20people&journal=Am%20J%20Kidney%20Dis&doi=10.1053%2Fj.ajkd.2008.01.014&volume=51&pages=904-913&publication_year=2008&author=Ansquer%2CJC&author=Dalton%2CRN&author=Causse%2CE&author=Crimet%2CD&author=Malicot%2CK&author=Foucher%2CC?
- How much does https://doi.org/10.1016%2FS0002-9149%2898%2900040-X bring in each month?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9526816 makes per month
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Long-term%20efficacy%20and%20safety%20of%20fenofibrate%20and%20a%20statin%20in%20the%20treatment%20of%20combined%20hyperlipidemia&journal=Am%20J%20Cardiol&doi=10.1016%2FS0002-9149%2898%2900040-X&volume=81&pages=60B-65B&publication_year=1998&author=Ellen%2CRL&author=McPherson%2CR?
- How much money does https://doi.org/10.1016%2Fj.amjcard.2007.03.003 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17599422 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Action%20to%20control%20cardiovascular%20risk%20in%20diabetes%20%28ACCORD%29%20trial%3A%20design%20and%20methods&journal=Am%20J%20Cardiol&doi=10.1016%2Fj.amjcard.2007.03.003&volume=99&pages=21i-33i&publication_year=2007&author=Buse%2CJB&author=Bigger%2CJT&author=Byington%2CRP bring in each month?
- How much does https://doi.org/10.1056%2FNEJMoa1001282 generate monthly?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20228404?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Effects%20of%20combination%20lipid%20therapy%20in%20type%202%20diabetes%20mellitus&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1001282&volume=362&pages=1563-1574&publication_year=2010&author=Ginsberg%2CHN&author=Elam%2CMB&author=Lovato%2CLC is on a monthly basis
- What are the total earnings of https://doi.org/10.1016%2Fj.amjcard.2007.03.024?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17599426's earnings
- How much money does http://scholar.google.com/scholar_lookup?&title=Evolution%20of%20the%20lipid%20trial%20protocol%20of%20the%20Action%20to%20Control%20Cardiovascular%20Risk%20in%20Diabetes%20%28ACCORD%29%20trial&journal=Am%20J%20Cardiol&doi=10.1016%2Fj.amjcard.2007.03.024&volume=99&pages=56i-67i&publication_year=2007&author=Ginsberg%2CHN&author=Bonds%2CDE&author=Lovato%2CLC generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16908915 earn?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Using%20standardized%20serum%20creatinine%20values%20in%20the%20modification%20of%20diet%20in%20renal%20disease%20study%20equation%20for%20estimating%20glomerular%20filtration%20rate&journal=Ann%20Intern%20Med&volume=145&pages=247-254&publication_year=2006&author=Levey%2CAS&author=Coresh%2CJ&author=Greene%2CT
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19414839's earnings
- Find out how much http://scholar.google.com/scholar_lookup?&title=A%20new%20equation%20to%20estimate%20glomerular%20filtration%20rate&journal=Ann%20Intern%20Med&volume=150&pages=604-612&publication_year=2009&author=Levey%2CAS&author=Stevens%2CLA&author=Schmid%2CCH earns monthly
- How much does https://doi.org/10.1097%2F00008571-200412000-00005 rake in every month?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15608561?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Response%20to%20micronized%20fenofibrate%20treatment%20is%20associated%20with%20the%20peroxisome-proliferator-activated%20receptors%20alpha%20G%2FC%20intron7%20polymorphism%20in%20subjects%20with%20type%202%20diabetes&journal=Pharmacogenetics&doi=10.1097%2F00008571-200412000-00005&volume=14&pages=823-829&publication_year=2004&author=Foucher%2CC&author=Rattier%2CS&author=Flavell%2CDM?
- Financial intake of https://doi.org/10.1016%2Fj.atherosclerosis.2005.08.012
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16165140 pull in monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Effect%20of%20rosiglitazone%20on%20homocysteine%20and%20creatinine%20levels%20in%20patients%20with%20type%202%20diabetes&journal=Atherosclerosis&doi=10.1016%2Fj.atherosclerosis.2005.08.012&volume=183&pages=367-368&publication_year=2005&author=Stulc%2CT&author=Kasalova%2CZ&author=Krejci%2CH&author=Dolezalova%2CR&author=Ceska%2CR
- https://doi.org/10.1016%2Fj.ejphar.2010.03.002's revenue stream
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20347778 each month?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=The%20low%20dose%20combination%20of%20fenofibrate%20and%20rosiglitazone%20halts%20the%20progression%20of%20diabetes-induced%20experimental%20nephropathy&journal=Eur%20J%20Pharmacol&doi=10.1016%2Fj.ejphar.2010.03.002&volume=636&pages=137-144&publication_year=2010&author=Arora%2CMK&author=Reddy%2CK&author=Balakumar%2CP?
- How much does https://doi.org/10.1056%2FNEJMoa0802743 rake in every month?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18539917
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20intensive%20glucose%20lowering%20in%20type%202%20diabetes&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0802743&volume=358&pages=2545-2559&publication_year=2008&author=Gerstein%2CHC&author=Miller%2CME&author=Byington%2CRP?
- Explore the financials of https://doi.org/10.2337%2Fdc09-0621
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19846798?
- How much does http://scholar.google.com/scholar_lookup?&title=Effects%20of%20long-term%20fenofibrate%20treatment%20on%20markers%20of%20renal%20function%20in%20type%202%20diabetes%3A%20the%20FIELD%20Helsinki%20substudy&journal=Diabetes%20Care&doi=10.2337%2Fdc09-0621&volume=33&pages=215-220&publication_year=2010&author=Forsblom%2CC&author=Hiukka%2CA&author=Leinonen%2CES&author=Sundvall%2CJ&author=Groop%2CPH&author=Taskinen%2CMR pull in monthly?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21052978?
- Profit of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20fenofibrate%20on%20renal%20function%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20the%20Fenofibrate%20Intervention%20and%20Event%20Lowering%20in%20Diabetes%20%28FIELD%29%20Study&journal=Diabetologia&doi=10.1007%2Fs00125-010-1951-1&volume=54&pages=280-290&publication_year=2011&author=Davis%2CTM&author=Ting%2CR&author=Best%2CJD
- Profit of https://doi.org/10.1159%2F000064083
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12372935
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Fenofibrate%20increases%20creatininemia%20by%20increasing%20metabolic%20production%20of%20creatinine&journal=Nephron&doi=10.1159%2F000064083&volume=92&pages=536-541&publication_year=2002&author=Hottelart%2CC&author=El%20Esper%2CN&author=Rose%2CF&author=Achard%2CJM&author=Fournier%2CA
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14999402?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Peroxisome%20proliferator-activated%20receptor%20alpha%20target%20genes&journal=Cell%20Mol%20Life%20Sci&doi=10.1007%2Fs00018-003-3216-3&volume=61&pages=393-416&publication_year=2004&author=Mandard%2CS&author=Muller%2CM&author=Kersten%2CS
- Find out how much https://doi.org/10.1152%2Fajpheart.00677.2004 earns monthly
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15374828?
- How much money does http://scholar.google.com/scholar_lookup?&title=Peroxisome%20proliferator-activated%20receptors%20and%20cardiovascular%20remodeling&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00677.2004&volume=288&pages=H1037-H1043&publication_year=2005&author=Schiffrin%2CEL generate?
- What's the financial gain of https://doi.org/10.1152%2Fajprenal.00004.2007?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17442729?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Increasing%20or%20stabilizing%20renal%20epoxyeicosatrienoic%20acid%20production%20attenuates%20abnormal%20renal%20function%20and%20hypertension%20in%20obese%20rats&journal=Am%20J%20Physiol%20Renal%20Physiol&doi=10.1152%2Fajprenal.00004.2007&volume=293&pages=F342-F349&publication_year=2007&author=Huang%2CH&author=Morisseau%2CC&author=Wang%2CJ?
- What's the financial intake of https://doi.org/10.1093%2Fbiomet%2F78.3.691?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20note%20on%20a%20general%20definition%20of%20the%20coefficient%20of%20determination&journal=Biometrika&doi=10.1093%2Fbiomet%2F78.3.691&volume=78&pages=691-692&publication_year=1991&author=Nagelkerke%2CNJD make?
- Get to know https://citation-needed.springer.com/v2/references/10.1007/s00125-012-2524-2?format=refman&flavour=references's earnings
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D.%20E.%20Bonds?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D.%20E.%20Bonds%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20E.%20Craven's earnings
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20E.%20Craven%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20Buse
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20Buse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20R.%20Crouse make?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20R.%20Crouse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=R.%20Cuddihy?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22R.%20Cuddihy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M.%20Elam net monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M.%20Elam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.%20N.%20Ginsberg generate monthly?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.%20N.%20Ginsberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=K.%20Kirchner?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22K.%20Kirchner%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S.%20Marcovina
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S.%20Marcovina%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.%20C.%20Mychaleckyj have monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.%20C.%20Mychaleckyj%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=P.%20J.%20O%E2%80%99Connor's earnings
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22P.%20J.%20O%E2%80%99Connor%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J.-A.%20Sperl-Hillen?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J.-A.%20Sperl-Hillen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- What's the profit of https://s100.copyright.com/AppDispatchServlet?title=Fenofibrate-associated%20changes%20in%20renal%20function%20and%20relationship%20to%20clinical%20outcomes%20among%20individuals%20with%20type%202%20diabetes%3A%20the%20Action%20to%20Control%20Cardiovascular%20Risk%20in%20Diabetes%20%28ACCORD%29%20experience&author=D.%20E.%20Bonds%20et%20al&contentID=10.1007%2Fs00125-012-2524-2©right=Springer-Verlag%20%28outside%20the%20USA%29&publication=0012-186X&publicationDate=2012-03-27&publisherName=SpringerNature&orderBeanReset=true?
- Earnings of https://citation-needed.springer.com/v2/references/10.1007/s00125-012-2524-2?format=refman&flavour=citation
- How much profit does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral generate?
- What's the income of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much does https://www.springernature.com/gp/products gross monthly?
- Learn how profitable https://www.springernature.com/gp/librarians is on a monthly basis
- How much does https://www.springernature.com/gp/societies make?
- How much revenue does https://www.springernature.com/gp/partners generate?
- How much does https://www.springer.com/ earn?
- What is the earnings of https://www.nature.com/?
- What's the revenue for https://www.biomedcentral.com/?
- How much cash flow does https://www.palgrave.com/ have monthly?
- How much does https://www.apress.com/ rake in every month?
- Financial intake of https://www.springernature.com/gp/legal/ccpa
- What's the total monthly financial gain of https://www.springernature.com/gp/info/accessibility?
- What is the monthly revenue of https://support.springernature.com/en/support/home?
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations pull in?
- Get to know https://www.springernature.com/'s earnings
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref